Adicet Bio Inc reports results for the quarter ended in September - Earnings Summary

ADICET Bio

09/11/2022 04:08

* Adicet Bio Inc  ACET.OQ  reported a quarterly adjusted
loss
of 53 cents​​ per share for the quarter ended in September. The
mean expectation of ten analysts for the quarter was for a loss
of 53 cents per share.
    * Reported revenue was zero​; analysts expected $333.33
thousand. 
    * Adicet Bio Inc's reported EPS for the quarter was a loss
of 53
cents​.
    * The mean earnings estimate of analysts had fallen by
about 8.5%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Adicet Bio Inc shares had risen by 34.7% this quarter and
gained 9.5% so far this year.
    * The company reported a quarterly loss of $22 million.
    * Wall Street's median 12-month price target for Adicet Bio
Inc is
$27.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 04:07 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.53          -0.53          Met
 Jun. 30 2022      -0.45          -0.56          Missed
 Mar. 31 2022      -0.18          0.10           Beat
 Dec. 31 2021      -0.42          -0.47          Missed